Sign In
Buy SNN
$29.36
-0.120 (-0.407%)
At Close: Jun 02, 2026
Smith & Nephew plc (SNN) Q2 2023 Earnings Call Transcript
02:39am, Friday, 04'th Aug 2023
Smith & Nephew plc (NYSE:SNN ) Q2 2023 Earnings Conference Call August 3, 2023 3:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Con
Smith & Nephew raises guidance after strong first half
02:44am, Thursday, 03'rd Aug 2023
Smith & Nephew PLC (LSE:SN) reported improved revenue, profit and margin in the first half making progress towards achieving sustainable higher growth under its 12-point plan. In the six months to Jul
Smith & Nephew: Entering New Markets But Growth Is Slow Still
04:44am, Tuesday, 01'st Aug 2023
Smith & Nephew plc is a long-standing company in the medical device sector, focusing on developing and manufacturing internationally. The company has recently received FDA clearance for its AETOS Shou
Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand
08:06am, Friday, 16'th Jun 2023
After a pandemic pause, hip and knee replacements are back. Long-postponed surgeries are being rescheduled, which is bad for business at insurance companies like UnitedHealth Group Inc. NYSE: UNH, but
Smith & Nephew holds guidance as revenue rises 3.8%
02:38am, Wednesday, 26'th Apr 2023
Smith & Nephew PLC (LSE:SN) held full-year guidance as it reported strong growth in its Sports Medicine and Advanced Wound Management businesses had underpinned an improvement in first quarter revenue
Smith & Nephew shares worth 'buying' up £16, says leading bank
09:11am, Monday, 17'th Apr 2023
RBC Capital said expects Smith & Nephew PLC (LSE:SN) to post revenue growth of 3.9% in the first quarter, as the company benefits from positive trends in US elective procedures while facing headwinds
3 Healthcare Dividend Payers With Big Price Growth
07:11am, Friday, 14'th Apr 2023
You don't see financial TV channels dedicated to minute-by-minute coverage of dividend yield or increases, but for investors in companies like Sanofi (NASDAQ: SNY), AstraZeneca plc (NASDAQ: AZN), and
Smith & Nephew's (SNN) CIT Technology Favored by New Study
09:12am, Friday, 24'th Mar 2023
Smith & Nephew (SNN) achieves a positive response for its COBLATION-Technology-infused Intracapsular Tonsillectomy Technique, providing fast patient recovery over existing surgeries.
Smith & Nephew (SNN) Simplifies ACL Surgery With New Offers
09:11am, Thursday, 09'th Mar 2023
Smith & Nephew (SNN) introduces QUADTRAC System and broadens ULTRABUTTON Adjustable Fixation Devices portfolio for ACL reconstruction.
What Makes Smith & Nephew (SNN) a New Buy Stock
01:33pm, Thursday, 23'rd Feb 2023
Smith & Nephew (SNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Smith & Nephew: Orthopedic Franchise Finally Coming Along
11:15am, Wednesday, 22'nd Feb 2023
Company reports top-line growth in Q4. Innovation & operational leverage finally turning the screw here.
Smith & Nephew plc (SNN) Q4 2022 Earnings Call Transcript
09:50pm, Tuesday, 21'st Feb 2023
Smith & Nephew plc (NYSE:SNN ) Q4 2022 Earnings Conference Call February 21, 2023 3:30 AM ET Company Participants Deepak Nath - CEO Anne-Francoise Nesmes - CFO Conference Call Participants Jack Reynol
Smith & Nephew annual profits fall as margins take a hit
02:57am, Tuesday, 21'st Feb 2023
Smith & Nephew PLC (LSE:SN) reported flat annual revenue but declining margins meant operating profit fell sharply. The global medical technology company said operating profit margins slipped to 8.6%
Smith & Nephew Is Reverting to Fair Value
04:04pm, Wednesday, 25'th Jan 2023
The medical device industry has undergone considerable consolidation in recent years, leaving a small number of competitors, and offers long-term growth potential due to increasing longevity, an aging
Smith & Nephew plc (SNN) Q3 2022 Earnings Call Transcript
05:13pm, Saturday, 05'th Nov 2022
Smith & Nephew plc (NYSE:SNN ) Q3 2022 Results Conference Call November 3, 2022 4:30 AM ET Company Participants Deepak Nath - Chief Executive Officer Anne-Francoise Nesmes - Chief Financial Officer Co
